$5.49 Million is the total value of BAIN CAPITAL INVESTORS LLC's 5 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SGRY | SURGERY PARTNERS INC | $2,007,817 | +23.7% | 58,248,249 | 0.0% | 36.55% | +3.9% | |
| DSEY | Buy | DIVERSEY HLDGS LTD | $1,917,194 | +90.2% | 236,983,211 | +0.2% | 34.90% | +59.7% |
| CERE | CEREVEL THERAPEUTICS HLDNG I | $1,478,823 | -22.7% | 60,632,356 | 0.0% | 26.92% | -35.1% | |
| AVAH | AVEANNA HEALTHCARE HLDGS INC | $84,865 | +33.3% | 81,600,880 | 0.0% | 1.54% | +12.0% | |
| ADV | ADVANTAGE SOLUTIONS INC | $4,566 | -24.0% | 2,890,000 | 0.0% | 0.08% | -36.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bain Capital Partners XII, LLC #1
- Bain Capital Fund XII, L.P. #2
- BCPE Perception GP, LLC #3
- BC Perception Holdings, LP #4
- Bain Capital Partners XI, L.P. #5
- Bain Capital Fund XI, L.P. #6
- BCPE Eagle GP, LLC #7
- BCPE Diamond GP, LLC #8
- BCPE Eagle Investor, LP #9
- BCPE Diamond Investor, LP #10
- BCPE Seminole GP LLC #11
- BCPE Seminole Holdings LP #12
- BCPE Seminole Holdings IV, L.P. #13
- BCPE Seminole GP II LLC #14
- BCPE Seminole GP III LLC #15
- BCPE Seminole Holdings II Intermediate LP #16
- BCPE Seminole Holdings III, L.P. #17
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICHAELS COS INC | 27 | Q1 2021 | 45.7% |
| GENPACT LIMITED | 26 | Q3 2019 | 43.3% |
| VERITIV CORP | 26 | Q4 2020 | 7.1% |
| ATENTO S A | 25 | Q4 2020 | 14.1% |
| SURGERY PARTNERS INC | 23 | Q1 2023 | 47.4% |
| BRIGHT HORIZONS FAM SOL IN D | 19 | Q4 2017 | 18.4% |
| QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 15.1% |
| IQVIA HLDGS INC | 16 | Q3 2021 | 17.2% |
| VONAGE HLDGS CORP | 13 | Q2 2016 | 0.0% |
| CEREVEL THERAPEUTICS HLDNG, INC. | 10 | Q1 2023 | 41.5% |
View BAIN CAPITAL INVESTORS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 4 | 2022-11-23 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 3 | 2022-07-11 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
View BAIN CAPITAL INVESTORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.